Aevumed SUPERCYNCH Button System
Aevumed, Inc. · Decision date Sep 2, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-09-02 for the Aevumed SUPERCYNCH™ Button System, submitted by Aevumed, Inc. of Malvern, Pennsylvania, under 510(k) number K253065. The device falls under regulation number 888.3040, classification name Fastener, Fixation, Nondegradable, Soft Tissue, product code MBI, with the orthopedic review panel and orthopedic medical specialty. The application was received on 09/22/2025 and reviewed as a traditional 510(k); the record states it was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan.
SESE denotes clearance of the 510(k) rather than premarket approval. The record identifies the device as a button system within a soft-tissue fixation classification but does not describe its components, materials, sizes, or intended surgical use, and no summary statement is present in the supplied data. Bench performance, biocompatibility, sterilization, and labeling content are likewise not available here, so the basis for the equivalence determination cannot be characterized from this record alone.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253065
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Aevumed, Inc.
- Product code
- MBI
- Decision code
- SESE
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Fastener, Fixation, Nondegradable, Soft Tissue.
- Applicant
- Aevumed, Inc.
- Product code
- MBI
- FDA device class
- 2
FDA decision timeline
K253065 received
Application receipt date recorded by FDA.
K253065 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MBI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Arthrex FiberButtonK263477 | ARTHREX, INC. | 510(k) clearance | Oct 27, 2026 | FDA |
| Smith & Nephew, Inc. | 510(k) clearance | Oct 23, 2026 | FDA | |
TeKBrace Knotless AnchorK263352 | TheraMicro | 510(k) clearance | Oct 21, 2026 | FDA |
| Anika Therapeutics, Inc. | 510(k) clearance | Sep 17, 2026 | FDA | |
ArthroTAK Tendon Anchor KitK262809 | ArthroTAK, LLC | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Aevumed, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Malvern, PA
Sources and methodology
- Original FDA record: K253065
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



